Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, August 5 at 2:00 PM EDT

Register Free →

Automated Cell and Sample Management Systems

Active
Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

General Info

Agency

Department Of Health And Human Services → National Institutes Of Health NidaView Agency

NAICS

541714 - Research and Development in Biotechnology (except Nanobiotechnology)View NAICS

Place of Performance

Rockville, MD, USA

Set-Aside

NONE

Documents

(0)

No documents available

AI Contract Breakdown

Uniform Contract Format

No contract breakdown available.

Cannot generate Contract Breakdown because no documents were found from this contract's source.

Timeline

Posted

subcontract

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencyDepartment Of Health And Human Services → National Institutes Of Health Nida
ContactsNo contacts available
OfficeN/A
Organization / Agency
Department Of Health And Human Services → National Institutes Of Health Nida
View Agency Profile
Office AddressN/A
ContactsNo contact information available

Full Description

Show more
Operation and maintenance of robotic systems for automated cell culture, sample handling, and biorepository management to support high-throughput screening workflows.

Similar Contracts

Same NAICS industry code

NAICS: 541714
New
Federal
AN11--36C25226R0084 - TBI research with Arraystar Inc FY2026
Solicitation # 36C25226R0084
The Department of Veterans Affairs is seeking information from potential vendors to support a sole source procurement for Methylated and hydroxymethylated DNA immunoprecipitation sequencing (MeDIP-seq and hMeDIP-seq) services under solicitation number 36C25226R0084. This effort is part of a TBI research project at the William S Middleton VA Medical Center in Madison, Wisconsin, aimed at understanding epigenetic changes—specifically the roles of 5-methylcytosine and 5-hydroxymethylcytosine—in secondary brain damage following trauma. The contract requires comprehensive sequencing and data analysis of mouse brain tissue samples from adult and aged males and females to identify sex- and age-specific patterns. The work must be performed using the same tissue samples for both MeDIP and hMeDIP to minimize variability and ensure reliable comparative results. The vendor will deliver raw sequencing data in Fastq format, quality control reports, analytical summaries, and final project reports in Excel, PDF, and PNG formats within 56 to 70 days of contract start. Submission of capability statements is required by August 10, 2026, via email only, with no phone inquiries accepted, and must include customer references and technical proof of capability. This is not a solicitation or request for proposals but a sources sought notice to justify a sole source award under 41 U.S.C. 1901, as the VA believes only one vendor can meet the highly specialized scientific requirements. The principal investigator will evaluate all submissions due to the technical nature of the research and will determine vendor suitability. The contract, if awarded, will be a firm fixed price agreement for one year, with no option periods, running from August 10, 2026, to August 9, 2027. All deliverables must be transmitted via USB drive, as the research laboratory operates in an affiliate space disconnected from the VA network. Responses must be emailed to Tiarrah Turner at the VA Great Lakes Acquisition Center in Milwaukee, Wisconsin, with attachments not exceeding 8 MB each. The government retains full discretion to proceed with sole source negotiation regardless of responses received. No federal funds are allocated under the Recovery Act for this procurement.
252-NETWORK Contract Office 12 (36C252)

POSTED

about 23 hours ago

DEADLINE

in 6 days
View Details
NAICS: 541714
New
Grant
Emerging Infections Network - Research for Preventing, Detecting, and Managing Travel-associated Infectious Diseases
Solicitation # RFA-CK-26-035
This funding opportunity aims to strengthen the detection, prevention, and management of infectious diseases among international travelers by establishing a robust research network focused on real-world surveillance and clinical insights. The initiative seeks to improve the speed and accuracy of outbreak detection, enhance understanding of disease progression, refine diagnostic and treatment approaches, and optimize genomic surveillance—all with the goal of advancing U.S. global health security. Research must directly address public health challenges linked to travel-associated infections, with an emphasis on generating actionable data that informs guidelines and improves patient care outcomes. The program includes two distinct but complementary components: a clinic-based sentinel network that collects clinical and epidemiological data from healthcare settings serving travelers, and a sentinel detection system embedded within international transportation hubs such as airports and seaports to capture early signals of emerging threats. Applicants may submit proposals for one or both components, but if a single applicant receives top scores for both, funding will be awarded only for Component B, ensuring resources are directed toward the most critical point of pathogen introduction. Applications must be submitted by November 5, 2026, through the CDC’s solicitation RFA-CK-26-035, with direct inquiries to the designated point of contact at the Centers for Disease Control and Prevention.
Centers For Disease Control And Prevention

POSTED

1 day ago

DEADLINE

in 3 months
View Details
NAICS: 541714
New
Federal
Presolicitation Notice - BARDA Vaccine Medical Countermeasures for Pandemic Influenza Preparedness & Response
Solicitation # 75A50126R00001_RFP_PreSolNotice_NPIVS-2027
BARDA is seeking qualified contractors to support the ongoing Vaccine Medical Countermeasures for Pandemic Influenza Preparedness and Response Program, requiring the provision of vaccines, antigens, and adjuvants to ensure rapid readiness for pandemic influenza or other viruses with pandemic potential. Contractors must deliver comprehensive services including manufacturing, regulatory documentation, and manufacturing readiness support, with a preference for U.S. based facilities. This includes generating and submitting all necessary analytical, nonclinical, clinical, and CMC data to the FDA, even during interpandemic periods, to enable timely regulatory decisions and sustain production capability. The program emphasizes continuous improvement of influenza vaccines with demonstrated feasibility and full lifecycle support from development through commercial-scale manufacturing. To be eligible, offerors must have a proven track record in influenza vaccine manufacturing, either by holding an active U.S. influenza vaccine license or by having successfully submitted a Biologics License Application for a seasonal or pandemic influenza vaccine. The solicitation, issued under number 75A50126R00001_RFP_PreSolNotice_NPIVS-2027, is open with a response deadline of August 15, 2026, and is administered by the Department of Health and Human Services through BARDA. All proposals must meet strict qualification criteria and align with the program’s goals of ensuring national preparedness, rapid response capacity, and regulatory compliance. Primary point of contact for inquiries is Laura Saddison at HHS.
Barda - Aspr / Daappo / Barda Dcma

POSTED

5 days ago

DEADLINE

in 11 days
View Details
NAICS: 541714
New
Federal
Convergence Special Notice
Solicitation # DARPA-SN-26-108
The Convergence program seeks to revolutionize environmental monitoring for defense operations by integrating synthetic biology and engineering to create advanced microbial biosensors capable of detecting chemical and pharmaceutical hazards in austere environments. Leveraging non-pathogenic microbial consortia built on well-characterized, safe host organisms like E. coli, the initiative focuses on developing modular biological systems that translate environmental inputs into standardized, detectable outputs. The program’s development follows a structured four-tiered approach, progressing from component-level design and integrated payload engineering to full system integration within a microbial chassis, ultimately aiming for a deployable platform ready for U.S. and international regulatory certification. This systematic progression ensures that each layer of functionality is rigorously validated before scaling to operational readiness. To enable safe, responsible, and globally viable deployment, the program includes a dedicated ecosystem of testing and collaboration. Performance and safety validation will first occur within the United States before exploring international adoption, with two specialized working groups guiding the process: one focused on navigating socio-political landscapes and local environmental regulations, and another managing cooperative use cases and deployment protocols with global allies. Administered by DARPA, the solicitation under number DARPA-SN-26-108 invites multidisciplinary teams in synthetic biology, environmental science, and engineering to contribute to this initiative, with responses due by August 6, 2026. The program is headquartered in Arlington, Virginia, and is led by Mark Salvador, with the goal of delivering a scalable, secure, and globally interoperable biosensor platform for the protection of military personnel.
Defense Advanced Research Projects Agcy

POSTED

5 days ago

DEADLINE

in 8 days
View Details
NAICS: 541714
New
Federal
Multimodal Sensor Integration and Signal Fusion EngineeringThe contract seeks integration of multiple sensing modalities into a unified platform designed for real-time pharmaceutical inspection, emphasizing synchronized signal correlation and advanced noise reduction techniques. The project requires the engineering of a robust system capable of fusing data from diverse sensor types to enhance detection accuracy, reliability, and speed in identifying product defects or anomalies during manufacturing processes. Development must ensure temporal and spatial alignment of signals, adaptive filtering for environmental and operational interference, and seamless interoperability across hardware and software components to support continuous, high-fidelity monitoring. This subcontract, under NAICS code 541714 and sponsored by the Advanced Research Projects Agency for Health within the Department of Health and Human Services, targets innovation in sensor fusion technologies with a specific focus on quality assurance in pharmaceutical production. The place of performance is designated as Washington DC with a zip code of 20005, and proposals must be submitted by August 20, 2026. The initiative aims to advance detection capabilities beyond conventional single-sensor approaches, enabling next-generation inspection systems that meet stringent regulatory standards through data-driven, real-time analytics.
Advanced Research Projects Agency For Health (arpa-H)

POSTED

7 days ago

DEADLINE

in 16 days
View Details
NAICS: 541714
New
Federal
Sources Sought – RRBS Sequencing Services
Solicitation # 36C241-26-AP-4037
The Department of Veterans Affairs is seeking qualified Service-Disabled Veteran-Owned Small Businesses and Veteran-Owned Small Businesses to provide Reduced Representation Bisulfite Sequencing services for a neurodegenerative disease research program involving approximately 269 de-identified human post-mortem choroid plexus tissue samples. The scope includes comprehensive sample handling and quality control, bisulfite conversion, library preparation, Illumina paired-end sequencing generating about 30 million read pairs per sample, and downstream bioinformatics analysis such as raw data alignment, methylation calling, and genome browser track generation, with an expected turnaround time of six to eight weeks. This notice is issued for market research purposes under the Veterans First Contracting Program and is intended to evaluate potential for a set-aside under the VA Rule of Two, ensuring opportunities for SDVOSBs and VOSBs. All interested parties must submit a capability statement detailing their technical expertise, business size and status as an SDVOSB or VOSB, and facility location by 11:00 AM EST on August 12, 2026, to Chelsea Cortright at Chelsea.Cortright@va.gov with the subject line referencing ID# 36C241-26-AP-4037. The opportunity is not a solicitation or request for proposals, and no contract will be awarded directly from this notice. The effort is managed by the 241-NETWORK Contract Office 01 based in Togus, Maine, with performance occurring in Bedford, Massachusetts, under NAICS code 541714 for analytical laboratory services. Additional inquiries can be directed to Jennifer Fiore, the secondary point of contact.
241-NETWORK Contract Office 01 (36C241)

POSTED

7 days ago

DEADLINE

in 8 days
View Details
NAICS: 541714
Federal
Research service necessary to execute a NAMRU SOUTH Zika study in Panama.
Solicitation # ERP_PR_1301393620
Naval Medical Research Unit South is seeking research services to support its Virology Department’s febrile and respiratory surveillance study, specifically in support of a Zika virus study in Panama. The government has conducted market research and determined that only Fundacion Ciudad del Saber possesses the unique capability to fully meet the technical and operational requirements of the study, making the procurement eligible for a sole source award under FAR 13.106-1(b)(i). No competitive solicitation exists, and this notice serves solely as an opportunity for other potential vendors to demonstrate their capability to perform the work. Interested parties must submit a capability statement not exceeding five pages in 10-point font or larger, containing detailed management, technical, and cost information with convincing evidence of their ability to fulfill the requirement. Submissions must be sent via email as a Word or PDF attachment to genaro.m.vasquez.ln@health.mil with the subject line “ERP PR_1301393620” no later than 12:00 PM local time on August 11, 2026. Responses consisting only of questions or requests for clarification will not be accepted. The government retains full discretion to proceed with a sole source award or open a competitive process based on the submissions received. The contracting office is located in Washington, DC, and the primary point of contact is Genaro Vasquez.
Naval Medical Research Unit South

POSTED

8 days ago

DEADLINE

in 7 days
View Details
NAICS: 541714
Grant
Limited Competition: Clinical and Translational Science Awards (CTSA) Program: Collaborative and Innovative Acceleration AwardThe Congressionally mandated Clinical and Translational Science Awards (CTSA) Program aims to accelerate the translation of scientific discoveries into practical treatments, diagnostics, and health interventions that enhance patient and public health by funding a national network of academic medical centers. This network provides essential infrastructure, expertise, training, and collaborative platforms needed to move research from the laboratory into clinical practice and community health settings. The current opportunity is a forecast for a limited competition soliciting applications for the Collaborative and Innovative Acceleration Award, designed to support the development and implementation of novel approaches, technologies, or models that amplify the impact of translational research and expedite the delivery of effective therapies to all populations. Funding is authorized under Sections 301 and 405 of the Public Health Service Act, and governed by Federal Regulations 42 CFR Part 52 and 2 CFR Part 200. Eligible organizations may apply under this limited competition, and proposals will undergo standard National Institutes of Health peer review, with funding awarded only to meritorious applications. The announcement is issued by the National Institutes of Health, under the Department of Health and Human Services, with specific inquiries directed to the Division of Clinical Innovation at NCATS. The forecast was posted on July 20, 2026, and further details can be accessed through the official grants.gov listing, though no set-aside type, NAICS code, or specific place of performance is indicated.
National Institutes Of Health

POSTED

15 days ago

DEADLINE

N/A
View Details

More opportunities from Department Of Health And Human Services → National Institutes Of Health Nida

Same awarding agency

NAICS: 541715
New
Federal
Pharmacology and Toxicology for Therapeutics Program (PTTP) IDIQ Contracts
Solicitation # 75N98026R00138
The National Institute on Neurological Disorders and Stroke plans to extend the ordering period of four existing multiple-award Indefinite Quantity Indefinite Delivery contracts under the Pharmacology and Toxicology for Therapeutics Program by two years, from September 12, 2026, to September 12, 2028. These contracts are held by SRI International, Southern Research, IIT Research Institute, and the University of Illinois Chicago, and they support critical preclinical pharmacology and toxicology studies essential for advancing therapeutic candidates toward FDA Investigational New Drug applications. The work includes in vivo pharmacokinetics, acute and chronic toxicity evaluations, safety pharmacology, genotoxicity and carcinogenicity assessments, and in vitro ADMET assays, serving both the NIH Blueprint Neurotherapeutics Network and external NIH-funded projects. The modification is authorized under 41 U.S.C. 3304(a)(1) and follows RFO procedures for sole-source actions, as no other sources are deemed capable of meeting the agency’s requirements. The effort is classified under NAICS code 541715 with a size standard of 1,000 employees and is governed by Executive Order 14275 and OMB Memorandum M-25-26. Interested parties may submit capability statements, express interest, or lodge objections by August 18, 2026, at 3:00 p.m. Eastern Time, electronically to Sneha Singh at sneha.singh@nih.gov, referencing solicitation number 75N98026R00138. All respondents must have an active SAM registration with a valid Unique Entity Identifier and Taxpayer Identification Number, along with a certified business size statement. The government will evaluate submissions to determine whether to proceed with the non-competitive modification or initiate a new competitive procurement. No formal competitive bidding is being requested, and the decision to extend the contracts rests entirely at the discretion of the government. The requirement is not being fulfilled under commercial item acquisition authorities, but responders may still indicate if they can satisfy the need with commercial solutions.
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

about 23 hours ago

DEADLINE

in 14 days
View Details
NAICS: 541690
Federal
Modification to Extend Services for Scientific, Operations and Administrative Resources (SOAR) Contract Program
Solicitation # OLAO-SSD-SOAR-NOI
The National Institutes of Health, through the National Institute on Drug Abuse, is executing a non-competitive extension of the Scientific, Operations, and Administrative Resources (SOAR) contract program to ensure uninterrupted support for critical biomedical research activities. The SOAR program consists of five indefinite-delivery, indefinite-quantity contracts held by Axle Informatics LLC, Gap Solutions, Inc., Kelly Services, Inc., Guidehouse Digital LLC, and 22nd Century Technologies, Inc., with a combined maximum ordering value of $3.6 billion. The current ordering period is set to expire on June 21, 2026, but this amendment extends the base ordering period by twelve months to June 21, 2027, and adds two optional six-month extensions extending through June 21, 2028. Crucially, the clause governing task order duration is being revised to permit task orders to extend up to thirty-six months beyond the conclusion of the full extended ordering period, providing necessary flexibility for a phased transition to a future competitive procurement. This extension does not increase the contract ceiling; the remaining available funds of approximately $2.17 billion will be used to fulfill new and existing task orders under the revised timeframe. The extension is justified under FAR 6.103-1 due to the uniquely specialized and highly technical nature of the services, which require deep institutional knowledge, scientifically fluent personnel such as bioinformaticists, molecular biologists, and clinical research coordinators, and seamless continuity to protect ongoing research investments, prevent disruption to NIH’s mission, and avoid costly and risky transitions. Only the incumbent contractors possess the necessary expertise and infrastructure to deliver these services without jeopardizing the integrity of active biomedical projects, benchmark studies, and translational science efforts. The effort is part of a broader HHS initiative to consolidate and refine professional service procurements and is intended as a temporary measure to allow sufficient time for a full and open competition to be planned, executed, and transitioned without operational interruption. Responses to this presolicitation are solicited through March 5, 2027, to assess potential alternatives, but award will proceed non-competitively unless compelling evidence demonstrates viable competition exists. All proposers must hold an active SAM registration, provide their Unique Entity Identifier, and certify their business size status, with submissions required via email to designated NIH points of contact.
Other Scientific and Technical Consulting Services

POSTED

5 months ago

DEADLINE

in 7 months
View Details